Alkem's Enzene powers into US with $70 m investment
Published on: Sept. 3, 2025, 11:49 p.m. | Source: The Economic Times
Enzene Biosciences, an Alkem Labs subsidiary, has inaugurated a new US manufacturing plant. The facility is located in New Jersey. This venture represents a $70 million investment. It aligns with calls to boost local pharma manufacturing. Enzene's technology offers cost-effective drug production. The company currently employs 50 people. Enzene plans to increase its workforce to 200.
